HETEROGENEITY OF THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY DUE TO VARIOUS UNDERLYING CONDITIONS OF CHRONIC PULMONARY DISEASE IN ELDERLY PATIENTS

被引：0
|
作者：
Inoue, S. [1 ]
Kaneko, T. [2 ]
Morita, S. [2 ]
Natsumeda, Y. [3 ]
Mizushima, S. [1 ]
机构：
[1] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan
[3] Yokohama City Univ, Grad Sch Med, Lab Clin Res, Yokohama, Kanagawa 232, Japan
来源：
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH | 2011年 / 65卷
关键词：
D O I：
10.1136/jech.2011.142976d.71
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [31] Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults
    Singleton, Rosalyn J.
    Butler, Jay C.
    Bulkow, Lisa R.
    Hurlburt, Debby
    O'Brien, Katherine L.
    Doan, William
    Parkinson, Alan J.
    Hennessy, Thomas W.
    VACCINE, 2007, 25 (12) : 2288 - 2295
  • [32] Analysis of Vaccination Rates of 23-Valent Pneumococcal Polysaccharide Vaccine in Hospitalized Patients with Diabetes
    Seagroves, Amy
    Reh, Christina S.
    Bischoff, Nathaniel
    Nally, Laura M.
    Singh, Jasjit
    DIABETES, 2017, 66 : A377 - A378
  • [33] Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
    Kazunari Satomura
    Toshitaka Nakahara
    Suketaka Iwanaga
    Megumi Noami
    Keiko Kusaka
    Kazuyoshi Harano
    BMC Health Services Research, 14 (Suppl 2)
  • [34] Immunogenicity of A 23-Valent Pneumococcal Polysaccharide Vaccine Among Mexican Children
    Elva Espinosa-Padilla, Sara
    Murata, Chiharu
    Estrada-Parra, Sergio
    Santos-Argumedo, Leopoldo
    Mascarenas, Cesar
    Franco-Paredes, Carlos
    Javier Espinosa-Rosales, Francisco
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (05) : 402 - 405
  • [35] EVALUATION OF PNEUMOCOCCAL TITERS AND RESPONSE TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CHILDREN WITH COUGH
    Anthony, K.
    Urrego, F.
    PEDIATRIC PULMONOLOGY, 2014, 49 : S78 - S78
  • [36] Clinical efficacy of 23-valent pneumococcal capsular polysacharide vaccine in COPD patients
    Muñoz, J
    Alfageme, I
    Reyes, N
    Merino, M
    Perez-Ronchel, J
    Lima, J
    CHEST, 2004, 126 (04) : 837S - 837S
  • [37] EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS (PRELIMINARY RESULTS)
    Tarasova, G. M.
    Belov, B. S.
    Naumtseva, M. S.
    Soloviev, S. K.
    Aseeva, E. A.
    Klyukvina, N. G.
    Popkova, T. V.
    Alexandrova, E. N.
    Novikov, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 474 - 474
  • [38] Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients
    Sumitani, Mitsuhiro
    Tochino, Yoshihiro
    Kamimori, Takao
    Fujiwara, Hiroshi
    Fujikawa, Terumichi
    INTERNAL MEDICINE, 2008, 47 (13) : 1189 - 1197
  • [39] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease
    Ulanova, Marina
    Huska, Brenda
    Desbiens, Angele
    Gaultier, Gabrielle N.
    Domonkos, Victoria
    McCready, William G.
    VACCINE, 2021, 39 (04) : 699 - 710
  • [40] Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine
    Rose, MA
    Schubert, R
    Strnad, N
    Zielen, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (10) : 1216 - 1222
12345